Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,309,000 | 2,745,000 | 1,372,000 | 4,873,000 | 4,049,000 |
| Depreciation Amortization | 6,284,000 | 4,205,000 | 2,074,000 | 8,698,000 | 6,622,000 |
| Income taxes - deferred | -682,000 | -405,000 | -389,000 | -2,889,000 | -1,498,000 |
| Accounts receivable | -180,000 | -524,000 | -702,000 | 66,000 | -273,000 |
| Accounts payable and accrued liabilities | -1,070,000 | -1,337,000 | 362,000 | 3,840,000 | 3,661,000 |
| Other Working Capital | -2,460,000 | -3,188,000 | 202,000 | 2,588,000 | 2,151,000 |
| Other Operating Activity | 5,557,000 | 4,815,000 | 1,121,000 | 5,663,000 | 3,374,000 |
| Operating Cash Flow | $11,758,000 | $6,311,000 | $4,040,000 | $22,839,000 | $18,086,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -683,000 | -434,000 | -193,000 | -777,000 | -572,000 |
| Net Acquisitions | -18,725,000 | -10,232,000 | -9,389,000 | -1,223,000 | -670,000 |
| Purchase Of Investment | -46,000 | -22,000 | -6,000 | -77,000 | -43,000 |
| Sale Of Investment | 516,000 | 9,000 | 6,000 | 55,000 | 41,000 |
| Other Investing Activity | -8,000 | -11,000 | -6,000 | 13,000 | 35,000 |
| Investing Cash Flow | $-18,946,000 | $-10,690,000 | $-9,588,000 | $-2,009,000 | $-1,209,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,008,000 | 5,008,000 | 5,008,000 | N/A | N/A |
| Debt Issued | 14,963,000 | 14,963,000 | 14,963,000 | N/A | 0 |
| Debt Repayment | -3,851,000 | -3,448,000 | -103,000 | -4,149,000 | -2,355,000 |
| Common Stock Issued | 204,000 | 137,000 | 127,000 | 180,000 | 149,000 |
| Common Stock Repurchased | -1,350,000 | -1,333,000 | -1,324,000 | -1,972,000 | -1,969,000 |
| Dividend Paid | -8,273,000 | -5,522,000 | -2,772,000 | -10,539,000 | -7,913,000 |
| Other Financing Activity | -5,051,000 | -5,083,000 | -5,080,000 | -742,000 | -685,000 |
| Financing Cash Flow | $1,650,000 | $4,722,000 | $10,819,000 | $-17,222,000 | $-12,773,000 |
| Exchange Rate Effect | -19,000 | -27,000 | -18,000 | 5,000 | -18,000 |
| Beginning Cash Position | 12,814,000 | 12,814,000 | 12,814,000 | 9,201,000 | 9,201,000 |
| End Cash Position | 7,257,000 | 13,130,000 | 18,067,000 | 12,814,000 | 13,287,000 |
| Net Cash Flow | $-5,557,000 | $316,000 | $5,253,000 | $3,613,000 | $4,086,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,758,000 | 6,311,000 | 4,040,000 | 22,839,000 | 18,086,000 |
| Capital Expenditure | -683,000 | -434,000 | -193,000 | -777,000 | -572,000 |
| Free Cash Flow | 11,075,000 | 5,877,000 | 3,847,000 | 22,062,000 | 17,514,000 |